ImmunoGen Inc (NASDAQ:IMGN)

14.00
Delayed Data
As of May 26
 +0.18 / +1.30%
Today’s Change
3.10
Today|||52-Week Range
14.91
+182.26%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 15.00, with a high estimate of 22.00 and a low estimate of 8.00. The median estimate represents a +7.14% increase from the last price of 14.00.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$42.8M
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.65%
 
 
 
 
 
 
Growthannually 40.15%
 
 
 
 
 
 

Sales

Growthquarterly -14.22%
 
 
 
 
 
 
Growthannually 82.24%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.